Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

NCT00065572 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell
Kidney Neoplasms

Interventions

DRUG: ZD6126
DRUG: Placebo

Sponsor

AstraZeneca